Regarding histopathology: active inflammation accounted for a high proportion (63.8% vs 27.5%); non-active inflammation (36.2% increase to 72.5%); atrophy (8.7% vs 5.8%); dysplasia (26.1% vs 1.4%), no significant change in intestinal metaplasia was found after treatment.